Assembly Biosciences Inc (NASDAQ: ASMB) has reported E.P.S. of $-1.66 for its first fiscal quarter (ending March 31) versus $-0.37 for the same period a year ago. For the latest four quarters through March 31, […]
The New York Times Company (NYSE: NYT) has reported E.P.S. of $0.25 for its first fiscal quarter (ending March 31) versus $0.14 for the same period a year ago — an increase of 79%. This […]
For its first fiscal quarter (ending March 31), Sapiens International Corp NV (NASDAQ: SPNS) has reported a 19% increase in E.P.S. from $0.26 a year ago to $0.31 in the current quarter. However, this performance […]
For its third fiscal quarter (ending March 31), The Hain Celestial Group Inc (NASDAQ: HAIN) has reported E.P.S. of $-0.54 compared to $-1.29 a year ago. This result fell short of the consensus estimate of […]
For its first fiscal quarter (ending March 31), Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has reported a -100% decline in E.P.S. from $0.31 a year ago to $0.00 in the current quarter. This performance was $-0.49 […]
For its fourth fiscal quarter (ending March 31), Steris Plc (NYSE: STE) has reported a -18% decline in E.P.S. from $1.89 a year ago to $1.55 in the current quarter. This performance was $-0.83 short […]
Myriad Genetics Inc (NASDAQ: MYGN) stock enjoyed a major increase of 21.1% on 5/8/24. The shares closed at $23.95. Moreover, exceptionally high trading volume at 376% of normal accompanied the advance. The stock has been […]
LCI Industries (NYSE: LCII) has reported earnings for its first fiscal quarter (ending March 31) of $1.44 versus $0.29 for the same period a year ago — an increase of 397%. This result exceeded the […]
Ziff Davis Inc (NASDAQ: ZD) has reported earnings for its first fiscal quarter (ending March 31) of $0.23 versus a loss $-0.16 for the same period a year ago. Relative to the consensus estimate of […]
On 5/8/24, Pacira BioSciences Inc (NASDAQ: PCRX) stock enjoyed a major increase of 11.8%, closing at $29.65. Moreover, exceptionally high trading volume at 386% of normal accompanied the advance. The stock has risen 13.0% during […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research